Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 5
2007 6
2008 5
2009 6
2010 8
2011 6
2012 14
2013 8
2014 15
2015 9
2016 10
2017 5
2018 8
2019 9
2020 9
2021 11
2022 11
2023 8
2024 9
2025 12
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer.
Burstein HJ, Curigliano G, Gnant M, Loibl S, Regan MM, Loi S, Denkert C, Poortmans P, Cameron D, Thurlimann B, Weber WP; Panelists of the St. Gallen International Breast Cancer Consensus 2025. Electronic address: https://twitter.com/SG_BCC; Panelists of the St. Gallen International Breast Cancer Consensus 2025. Burstein HJ, et al. Ann Oncol. 2025 Dec;36(12):1433-1446. doi: 10.1016/j.annonc.2025.09.007. Epub 2025 Oct 8. Ann Oncol. 2025. PMID: 41072918 Free article.
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ. Baek SY, et al. Among authors: kim sy. J Clin Oncol. 2023 Nov 1;41(31):4864-4871. doi: 10.1200/JCO.23.00557. Epub 2023 Aug 22. J Clin Oncol. 2023. PMID: 37607321 Clinical Trial.
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.
Jung SH, Koh Y, Kim MK, Kim JS, Moon JH, Min CK, Yoon DH, Yoon SS, Lee JJ, Hong CM, Kang KW, Kwon J, Kim KH, Kim DS, Kim SY, Kim SH, Kim YR, Do YR, Mun YC, Park SS, Park YH, Shin HJ, Eom HS, Yoon SE, Hwang SM, Lee WS, Lee MW, Yi JH, Lee JY, Lee JH, Lee HS, Lim SN, Lim J, Yhim HY, Chang YH, Jo JC, Cho J, Cho H, Choi YS, Cho HJ, Ahn A, Choi JH, Kim HJ, Kim K. Jung SH, et al. Among authors: kim sy. Blood Res. 2025 Feb 4;60(1):9. doi: 10.1007/s44313-025-00055-9. Blood Res. 2025. PMID: 39903326 Free PMC article. Review.
Correction: Evidence‑based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.
Jung SH, Koh Y, Kim MK, Kim JS, Moon JH, Min CK, Yoon DH, Yoon SS, Lee JJ, Hong CM, Kang KW, Kwon J, Kim KH, Kim DS, Kim SY, Kim SH, Kim YR, Do YR, Mun YC, Park SS, Park YH, Shin HJ, Eom HS, Yoon SE, Hwang SM, Lee WS, Lee MW, Yi JH, Lee JY, Lee JH, Lee HS, Lim SN, Lim J, Yhim HY, Chang YH, Jo JC, Cho J, Cho H, Choi YS, Cho HJ, Ahn A, Choi JH, Kim HJ, Kim K. Jung SH, et al. Among authors: kim sy. Blood Res. 2025 Apr 8;60(1):23. doi: 10.1007/s44313-025-00074-6. Blood Res. 2025. PMID: 40198482 Free PMC article. No abstract available.
Recent Updates of PET in Lymphoma: FDG and Beyond.
Kim SY, Chung HW, So Y, Lee MH, Lee EJ. Kim SY, et al. Biomedicines. 2024 Oct 29;12(11):2485. doi: 10.3390/biomedicines12112485. Biomedicines. 2024. PMID: 39595051 Free PMC article. Review.
158 results